nifedipine has been researched along with misoprostol in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Castillo Palma, MJ; Sánchez-Román, J; Talegón Meléndez, A; Varela-Aguilar, JM | 1 |
Hardy, KJ; Shulkes, A; Tancheroen, S | 1 |
Chao, A; El-Sayed, YY; Sapugay, AM | 1 |
Bernsand, M; Björkqvist, M; Eliasson, L; Håkanson, R; Lindström, E | 1 |
2 trial(s) available for nifedipine and misoprostol
Article | Year |
---|---|
[Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex].
Topics: Adult; Aged; Alprostadil; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Misoprostol; Nifedipine; Raynaud Disease; Regional Blood Flow | 1997 |
Does nifedipine prevent the tachysystole associated with misoprostol induction?
Topics: Administration, Intravaginal; Administration, Oral; Female; Humans; Labor, Induced; Misoprostol; Nifedipine; Oxytocics; Pregnancy; Tocolytic Agents; Uterine Contraction; Uterine Diseases; Uterus | 2002 |
4 other study(ies) available for nifedipine and misoprostol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hepatic ischemia-reperfusion injury modification during liver surgery in rats: pretreatment with nifedipine or misoprostol.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Hepatectomy; Liver; Liver Diseases; Liver Function Tests; Male; Misoprostol; Nifedipine; Organ Size; Oxytocics; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury | 1995 |
Somatostatin, misoprostol and galanin inhibit gastrin- and PACAP-stimulated secretion of histamine and pancreastatin from ECL cells by blocking specific Ca2+ channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Anti-Ulcer Agents; Calcium; Calcium Channels; Cells, Cultured; Chromogranin A; Dose-Response Relationship, Drug; Enterochromaffin-like Cells; Exocytosis; Galanin; Gastrins; Histamine; Hormones; Male; Microscopy, Video; Misoprostol; Models, Biological; Nifedipine; Pancreatic Hormones; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Somatostatin; Time Factors | 2005 |